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Abstract 
Background: Iron overload influences negatively on bone mineral density (BMD) but the 
results of studies regarding serum ferritin (SF) and BMD are conflicting.This study aimed 
to determine the association of SF and BMD in the elderly. 
Methods: All participants of the Amirkola cohort selected between 2011-2012, aged > 60 
years were classified as high or normal (<200ng/ml) SF. BMD at femoral neck and lumbar 
spine was determined by dual energy x-ray absorptiometry (DXA) and the results were 
expressed as BMD g/cm2 and BMDT-score. Multiple logistic regression analysis with 
calculation of odds ratio (OR) and 95% confidence interval was used to estimate the 
association of low BMD (LBMD) defined as BMD T-score < -1 with SF. 
Results: 1089 subjects (women, 44.7%) were studied. High SF was observed in 366 
(33.6%) and LBMD in 874 (80.2%) subjects. The two groups of SF were similar regarding 
biochemical parameters and demographic characteristics except MetS, overweight /obesity 
and diabetes which were more prevalent in high SFgroup. BMD g/cm2 at both 
measurement sites was significantly higher (P=0.001 for both) and the prevalence of 
LBMD was significantly lower (74.1% vs 83.1%, P=0.001) in high SF group by OR= 0.60 
(0.44-0.81). After adjustment for all biochemical and demographic variables, the 
association remained significant by adjusted OR= 0. 68 (0.49-0.94). 
Conclusions: These findings show a negative association between high SF and LBMD 
indicating a beneficial effect of high SF in the elderly. Regarding detrimental effect of iron 
overload on bone mass, these findings require further studies. 
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Osteoporosis is prevalent in the elderly and in postmenopausal women is an 
important cause of bone fracture and morbidity (1). Many factors such as age, sex, 
hormonal and metabolic disorders, physical inactivities, and smoking are associated with 
bone loss and low bone mineral density (BMD) (2-6). However, in the elderly subjects, 
coexistent of several chronic medical conditions may provide further susceptibility to bone 
loss. Serum ferritin (SF) which  is a marker of iron stores increases by age in both men and 
women, and in healthy state, its levels ranges from 40-200 ng/ml. On the other hand, SF is 
also a marker of inflammation which may increase in patients with coexistent chronic 
systemic inflammatory diseases (6). An association between excess iron and osteoporosis 
as well as fracture has been shown which is attributed to detrimental effect of iron on bone 
(7-9). Iron overload decreases osteoplastic activity and facilitates osteoplastic 
differentiation and bone resorption, furthermore, iron inhibits differentiation of bone 
marrow mesenchymal cells and bone remodelling, through induction of ferritin (9). In 
postmenopausal women, excess iron independently affects bone metabolism and leads to 
low BMD (8). 
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High level of SF and low BMD are observed in a number 
of chronic hematological diseases with iron overload such as 
thalassemia or sickle cell disease (10, 11), nonetheless, iron 
deposition does not explain low BMD in all cases of 
thalassemia (10) and in patients with hematopoietic 
disorders, low BMD, may be related to not only SF,but also 
to increased cellularity of bone marrow (11). The 
relationship between SF and BMD has been addressed in a 
few studies with conflicting results (4, 7, 12-15). In a study  
on the data from the 2008-2010 Korean National Health and 
Nutrition Examination Survey, comprised 7300  pre and 
postmenopausal women, Chon et al. found a negative 
correlation between SF and low BMD only in the lumbar 
spine (LS) BMD but not  in the femoral neck (FN)BMD in 
premenopausal women (7). Lee et al. in a study of 2,943 
subjects aged 65 years and over, found a significantly 
positive association between high SF and BMD at both FN 
and LS measurement sites  only in men but not in women 
(13).  
These observations indicate variations in the relationship 
between SF and BMD according to age, sex or BMD 
measurement sites. Furthermore, the causes of change in 
serum ferritin are also important. Since SF as an acute phase 
reactant, may change in response to inflammatory process 
and increases in subjects with chronic inflammatory diseases 
such as obesity, diabetes, chronic obstructive pulmonary 
disease (COPD), (6, 16).  
These conditions are prevalent in the general population 
as well as in the elderly people (6, 16). Thus, not only the SF 
but also the metabolic component of these entities may affect 
BMD .This context is less studied and data in this field are 
scarce. We therefore performed the present study to 
determine the association between SF and BMD in a cohort 
of elderly men and women comprised all inhabitants of a 
small town.  
 
 
Methods 
The data of this study extracted from the  phase 1 of the  
Amirkola Health and Aging Project (AHAP) cohort study. 
This longitudinal study cohort study  started  in 2011 and 
data collection is repeated every five years (17, 18).  All 
inhabitants of Amirkola, Babol, Iran aged 60 years and over 
were invited to participate in this project and finally 72.3% 
of the invited subjects completed the study. All eligible 
participants entered the study except subjects taking iron 
containing drug transfusion, antiosteoporotic therapy, 
chronic systemic or localized inflammatory diseases, current 
thyroid diseases, hormonal replacement therapy and subjects 
with impairment in daily physical activities. SF was assessed 
by standard method and the participants were classified as 
high or normal SF group according to SF values > 200 or < 
200 ng/ml respectively. BMD in the FN and LS was 
determined by dual energy x-ray absorptiometry (DXA) 
method using Lexxuss densitometer, and the results were 
expressed as BMD g/cm
2
, BMD T-score and BMD Z-score. 
Furthermore, data were provided for demographic features 
like age, sex, level of education, physical activity, quadriceps 
muscle strength, frequency of common medical conditions 
such as obesity, diabetes, metabolic syndrome (MetS), 
chronic lung and kidney diseases and anemia.  
Biochemical parameters such as serum iron, total iron 
binding capacity, serum calcium, serum 25-hydroxyvitamin 
D (25-OHD) were also determined. Details of patient 
selection, data collection regarding demographic features and 
biochemical tests have been described elsewhere (19). In 
brief information with regard to demographic characteristics, 
physical activity, and medication was provided by interview, 
review of medical records and fill-in questionnaire. Sample 
size was estimated to detect a 10% difference in the 
prevalence of low BMD (LBMD) between subjects of the 
two groups of high and normal SF. LBMD was defined as 
BMD T-score < - 1 at either FN or LS. Based on an expected 
50% prevalence of LBMD (3), a sample of 388 patients for 
each group would yield a power of 80 % and confidence 
interval of 95%. However, we included all participants to 
compensate the missed data as well as to increase power of 
the study. 
In statistical analysis, the two groups of patients with 
normal and high SF were compared regarding prevalence of 
LBMD, FN-BMD g/cm
2
, LS-BMD g/cm
2
. The association of 
SF with LBMD was determined using chi square test with 
calculation of odds ratio (OR) and 95% confidence interval 
(95% CI). Independent association between SF and LBMD 
was determined using multiple logistic regression analysis 
with LBMD as dependent and SF as independent variable 
after adjusting for all covariates. A  p-value less than 0.05 
was considered  significant. SPSS 21 was used to analyze the 
data. Informed consent was obtained from all the 
participants. The proposal of this study was approved by the 
Ethics Committee of Babol Univirsity of Medical Sciences, 
Babol, Iran 
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Results 
A total of 1089 patients (487 women with mean age of 
67.8+6.8 years and 602 men with mean  age of 68.7+6.6 
years (P=0.027) entered the study. High SF was observed in 
366 (33.6%) patients (females, 47.6%) and LBMD was seen 
in 847(80.2%) patients. Characteristics of patients with high 
and normal SF are shown in table 1. In the whole number of 
patients, high and normal SF groups were similar regarding  
mean age, physical activity, muscle strength, hemoglobin 
concentration, serum calcium, serum 25-OHD concentration, 
level of education and proportion of anemia (table 1). But, 
the proportion of MetS, overweight/obesity and diabetes was 
significantly higher in high SF group. Furthermore, serum 
iron concentrations and BMI were higher and TIBC was lower 
in high SF as compared with normal SF group. The BMD 
g/cm2 in both FN and LS measurement sites was 
significantly higher in high SF (P=0.001 for both) as 
compared to normal SF group (table 1). 
 
Table1. Characteristics of the study population according to serum ferritin (SF) levels 
Variables High SF 
(> 200 ng/ml) 
(n=366) 
Normal SF(<200ng/ml) 
(n=723) 
P values
&
 
 
Age (year) (mean±SD) 68 +6.8 68.7+7.1 0.17 
Female,no (%) 156(47.6) 331(45.8) 0.17 
BMI (kg/m
2
) mean±SD)   27.8+4.3 26.9+4.6 0.002 
Overweight/obesity 
£
 265 (67) 451 (63.2) 0.001 
Metabolic syndrome, no (%) € 292 (79.8) 507 (70.1) 0.001 
Diabetes, no (%) 158 (43.6) 181 (25.1) 0.001 
Physical activity score
,@
 11+65 11o.6+62.6 0.15 
Quadriceps muscle strength (kg), mean±SD 23.5+10.5 22.5+10.5 0.16 
FNBMD (g/cm
2)
, mean±SD
₩
 0.865+0.164 0.833+0.150 0.0013 
LSBMD (g/cm
2)
, mean±SD
¥
 0.888+0.189 0.855+0.185 0.0059 
Serum iron (mc/ml) 91.6+34.1 81.9+35.3 0.001 
Serum TIBC * (mc/ml) 277.4+38.5 284.7+38.6 0.004 
Hemoglobin (gr/dl) 13.8+1.6 13.7+1.4 0.30 
Anemja
$
, no (%)  65(17.6) 117(16.2) 0.28 
Low BMD
#
, no (%)  273(74.6) 601(83.1) 0.001 
Vitamin D (ng/ml) (mean±SD) 32.6+28 35.2+34.1 0.12 
Calcium (mg/dl) (mean±SD) 9.2+4.4 9.2+4.3 0.17 
Level of education, no(%) 
      Illiterate 
     Primary and high school 
     College 
 
238(65) 
96(26.2) 
32(8.7) 
 
429(59.3) 
238(71.3) 
56(7.7) 
 
0.077 
0.074 
0.25 
& Analysis was performed using t-test or chi square test                                        ☆ Quadriceps muscle strength  
£   < 25  Normal weight  25-29.=overweight,  > 30  Obesity                                   * Total Iron binding capacity 
$Defined as hemoglobin < 13 gr/dl in men and > 12 gr/dl in women     ¥Lumbar spine BMD     # Defined as BMD T-score < - 1                               
@Determined by PAS questionnaire   € Diagnosed based on ATP III criteria        ₩ Femoral neck BMD     
 
Subgroup analysis according to sex demonstrated a 
significant association between  high SF and diabetes as well 
as serum iron in both men and women. whereas, in men, 
high SF was also associated with MetS and obesity/ 
overweight  (table 2). The prevalence of LBMD was 
significantly lower in high SF group (74.6% vs 83.1%, OR=  
 
0.60, 95% CI, 0.44-0.81, P=0.001). After adjusting for all 
covariates (table 1), the negative association between high 
SF and LBMD remained at significant level with adjusted 
OR=0.68, 95% CI, 0.49-0.94, P=0.001) (table 3). 
Furthermore, there was a significantly negative association 
of LBMD with MetS, and a notably positive association 
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between LBMD and female sex (table 3). As compared with 
age group of 60-65 years, there was remarkably positive 
association between LBMD and aging with a dose- response 
pattern of relationship as well. 
 
Table 2. Association between serum ferritin (SF) and low bone mineral density (LBMD) in the elderly subjects aged 60 
years and more after adjustment for other aassociated factors with the calculation of  adjusted odds ratio and 95% 
confidence interval (95% CI) 
Variables Adjusted OR(95%CI) Pvalue 
SF > 200 vs <200 ng/ml 0.68 (0.49-0.94) 0.001 
Metabolic syndrome 
¥
 
presence vs absence 
 
0.42(0.28-0.63) 
0.001 
Females vs  males 4.04(2.8-5.8) 0.001 
Age groups   
60-64 1 - 
65-69 1.04(0.70-1.53) 0.83 
70-74 1.78(1.10-2.8) 0.018 
75-79 2.85(1.59-5.11) 0.001 
80-84 4.17(1.60-10.8) 0.003 
>   85 3.61(0.8-16.1) 0.093 
¥ Diagnosed by ATP III criteria 
Statistical analysis was done using multiple logistic regression analysis. 
Table 3.Associated factors of high serum ferritin in the study population according to sex 
 Men Women 
 > 200 
N=210 
< 200 
N=392 
p value > 200 
N=156 
< 200 
N=331 
pvalue 
Age (year) (mean±SD) 68.1±6.7 69.4±7.4 0.034 67.9±7 67.8±6.6 0.87 
Overweight/obesity 
£
 149(70.9) 208(53) 0.001 116(74.3) 243(73.4) 0.88 
Metabolic Syndrome, no (%) 
€
 149(71) 211(53.8) 0.001 143(91.7) 296(89.4) 0.44 
Diabetes, no (%) 70(37.8) 84(21.5) 0.02 79(51.6) 97(29.4) 0.0027 
Vitamin D (ng/ml) 31.3±25.9 32. 9±30.5 0.49 34.3±30.7 38.6(37.8) 0.18 
Calcium (mg/ml) 9.2±0.41 9.2±0.45 0.10 9.2±0.46 9.2 ± 0.42 0.10 
Physical activity score (mean±SD) 
@
 113.8±71.2 105±68.6 0.13 120±57.6 116±54.1 0.45 
Muscle strength (kg) ☆ 29±9.5 28.1±10 0.20 15.9±6.3 15.9±6.5 0.10 
Serum iron (mean±SD) 94.3±34.5 86.6±37.4 0.013 87.8 ±33.2 76.2±31.6 0.001 
TIBC (mean±SD) 
&
 276.7±7 38 282±39 0.10 278 ± 39.2 287±37.8 0.10 
Hemoglobin gr/dl) (mean±SD) 13±1.5 13±1.4 0.10 13 ±1.54 13±1.2 0.10 
Anemia, no (%) 
$ 
 34(16.2) 57(14.5) 0.82 31(19.9) 60(18.1) 0.83 
FN-BMD (g/cm2) (mean±SD) 
₩
 0.918±0.156 0.875±0.146 0.001 0.755±0.148 0.784±0.140 0.036 
LS-BMD (g/cm2) (mean±SD)  
¥
 0.955±0.179 0.921±0.180 0.027 0.799±0.163 0.777±0.159 0.15 
LBMD, no (%) 
# 
 140(66.6) 301(76.7) 0.025 133(85.2) 300(90.6) 0.098 
Education levels, no (%) 
Illiterate 
Primary and secondary school 
High school & College 
 
128(61) 
51(24.3) 
31(14.8) 
 
226(57.6) 
119(30.3) 
47(12) 
 
0.53 
0.42 
0.72 
 
110(70.5) 
45(28.8) 
1(0.6) 
 
203(61.3) 
119(36) 
9(2.7) 
 
0.10 
0.38 
0.89 
& Analysis was performed using t-test or chi square test    £ < 25  Normal weight  25-29.=overweight,  > 30  Obesity   € Diagnosed based on ATP III criteria     
&Total Iron binding capacity         ₩  Femoral neck BMD      ¥ Lumbar spine BMD    @ Determined by PAS questionnaire     
☆ Quadriceps muscle strength kg     $ Defined as hemoglobin < 13 gr/dl in men and > 12 gr/dl in women       #  Defined as BMD T-score < - 1 
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Discussion 
The findings of this study indicate that high SF in the 
elderly people aged 60 years and more is associated with 
lower prevalence of LBMD at both femoral neck and lumbar 
spine. There was also a positive dose-response pattern of 
association between LBMD and age, as well as a negative 
association between MetS and LBMD. These findings are 
consistent with the results of earlier studies (4,13,20). A 
positive association of high SF and BMD in all B7MD 
measurement sites has been reported in the elderly men aged 
> 65 years (13). Another study found an independent 
positive association between BMD and serum ferritin in 
postmenopausal women (4). In a retrospective analysis of 
postmenopausal women without hematological disorders 
aged 60-83 years, Mousal et al. found a positive association 
between SF and BMD at both FN and LS (20). 
Nonetheless, a number of studies found a negative 
association between SF and BMD. Chon et al. discovered a 
trend toward decreased LS-BMD only in premenopausal but 
not in postmenopausal women, whereas there was no 
association between SF and FNBMD (7). Similarly, Kim et 
al. in a population based cross-sectional study found an 
inverse association of SF with BMD at all measurement sites 
only in women > 45 years of age and an increased odds of 
prevalent osteoporosis and fractures in high SF quartiles 
(21). A similar negative association between SF with 
LSBMD and FNBMD has been reported in women aged > 
48 years (14). In a study of women with hip fractures, SF > 
150 ng/ml was associated with L BMD and SF was 
negatively correlated with both FN-BMD and LSBMD and 
positively with bone turnover markers (18).  
A 3-year retrospective longitudinal study of the elderly 
men and women showed a relationship between SF and 
BMD loss. In addition, there was a dose- response 
association between SF and the rate of BMD loss at all 
proximal femur regions in both men and women. The 
authors found iron stores as an independent risk factor of 
accelerated bone loss even in healthy women. A negative 
correlation of SF and BMD changes has been observed in 
patients with hematopoietic diseases with abnormal 
proliferation of bone marrow cells (11). 
Variations in the relationship between SF and BMD 
across different studies may be attributed to factors such as, 
study design, age, sex, and site of BMD measurement. 
Nevertheless, coexistence of disease conditions especially 
chronic lung and renal diseases, diabetes, MetS, and obesity 
which are prevalent in the general population as well as in 
elderly patients can confound the results (12, 22-24). These 
conditions are usually associated with inflammatory process 
and thus, may impress on both SF and BMD sera (6, 25). In 
the present study, high SF was significantly associated with 
MetS, diabetes and overweight/obesity. All of these 
conditions are associated with high BMD and increased level 
of SF (4, 5, 26-28).  
Although, the significant negative association between 
SF and LBMD in the present study remained statistically 
significant after adjustment of these conditions, but 
coexistence of obesity in all mentioned conditions justifies a 
possible confounding effect of  growth hormone/insulin 
growth factor-1 axis (29). These observations suggest that, 
studies which address the issue of SF and BMD in the 
elderly should consider the confounding effects of obesity-
related factors which can affect on both BMD and SF (26-
32). The results of studies have limitations regarding study 
design in which the association does not indicate causality. 
In statistical analysis, we did not compare men and women 
separately. The prevalence and the associated factors of 
osteoporosis in men are different from women (4, 5), yet, the 
results would not be affected, because distributions of  these 
factors are expected to be similar across the two comparison 
groups. Lack of data regarding the cause of high serum 
ferritin is another limitation.  The strength of this study is 
dependent on patient selection which comprised all the 
inhabitants of a town. Another strength is homogeneity of 
the study population regarding ethnicity, lifestyle, and other 
associated factors of bone loss.  
In conclusion, the findings of this study indicate a 
positive association between SF and BMD in the elderly 
people aged 60 years and older. Regarding the negative 
effect of iron overload on bone mass and contradicting 
results across relevant studies, this context needs further 
investigations with emphasis on age, gender of the study 
population, BMD measurement sites and in particular coexistent 
chronic medical diseases in the older subjects. Many chronic 
coexisting diseases in the elderly affect SF and BMD 
differently and so may result in unexpected findings. 
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